Oxidative stress and rheology in severe malaria

A M Dondorp1, F Omodeo-Salè, K Chotivanich

  • 1Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. AMDondorp@Yahoo.com

Insights

Malaria infection releases haemozoin, causing oxidative damage and red blood cell rigidity. The antioxidant N-acetylcysteine shows promise for treating severe malaria by protecting against this cellular damage.

Area of Science:

  • Biochemistry
  • Pathophysiology
  • Pharmacology

Background:

  • Haemozoin (beta-haematin) release during malaria infection is linked to oxidative damage.
  • Oxidative stress damages red blood cell membranes, increasing cell rigidity.
  • This rigidity contributes to severe malaria pathophysiology by impeding microcirculation.

Purpose of the Study:

  • To investigate the role of haemozoin-induced oxidative damage in red blood cell rigidity.
  • To evaluate N-acetylcysteine as a potential adjunctive therapy for severe malaria.

Main Methods:

  • Review of evidence linking haemozoin release to oxidative mechanisms.
  • Analysis of the impact of red blood cell membrane oxidation on cell deformability.
  • Consideration of N-acetylcysteine's antioxidant properties in the context of malaria.

Main Results:

  • Haemozoin release causes oxidative damage to red blood cell membranes.
  • Oxidized red blood cells become rigid, hindering microcirculation.
  • This rigidity represents a potential therapeutic target in severe malaria.

Conclusions:

  • Oxidative damage to red blood cells is a key factor in severe malaria.
  • N-acetylcysteine's antioxidant capacity makes it a promising adjunctive treatment.
  • Targeting red blood cell rigidity could improve outcomes in severe malaria.